Oaklins' professionals understand the regulatory, reimbursement, technological, medical and patient environments locally and around the world. We know the key players and can take a global perspective on any M&A deal. We identify the right strategic partners, maximize synergy potential and realize premium valuations for our clients. That's the Oaklins way.
9 May 2017
Our client, SFM Group, is going to attend the world’s largest global biotechnology event BIO 2017 International Convention taking place from 19–22 June 2017 in San Diego, USA. SFM Group, is an innovative Russian pharmaceutical company specializing in pharma R&D and has its own production facilities. Its product portfolio includes medicines to treat cardio-vascular diseases, viral infections,…
30 November 2016
Oaklins’ team in Switzerland advised the shareholders of TEM Group on the sale of the company to Instrumentation Laboratory (IL). Read more about the transaction, market trends, deal drivers and M&A valuation aspects.
29 September 2016
The owners of Sphinx Werkzeuge AG have sold a majority stake in the company to Helvetica Capital AG and members of the management team. Financial details were not disclosed. Sphinx Werkzeuge is a leading precision tools developer and manufacturer for high precision mechanical and medical applications. The company’s core business is the production of micro…
26 September 2016
Instrumentation Laboratory (IL) acquired CA Casyso AG (Basel, Switzerland) and its Tem subsidiaries (Tem), a global leader in in vitro diagnostic (IVD) testing for Patient Blood Management (PBM) with their flagship ROTEM testing systems. Tem is a global leader in in-vitro-diagnostic (IVD) testing for Patient Blood Management (PBM) with their flagship ROTEM testing systems. With…
29 April 2016
Smith & Williamson advised the shareholders of Oakleaf Care (Hartwell) Limited (Oakleaf) on the sale of the company to CareTech Holdings Plc (CareTech). Read more about the transaction, market trends, deal drivers and M&A valuation aspects.
26 November 2015
HEALTHCARE DEAL FLASH: Oaklins’ Swedish and Italian teams advised the shareholders of Xbrane Biosciences AB (Xbrane) on the acquisition of Primm Pharma. They supported the buyer by scouting the Italian market, identifying the most suitable target, and assisting in the LOI formulation and in negotiations throughout the process. Through the acquisition, Xbrane will be able…
16 October 2015
HEALTHCARE DEAL FLASH: Our Oaklins’ team in the Netherlands and Cavendish, an Oaklins member firm in the UK, advised the shareholders of C.D.C. Complete tandzorg (CDC) in the sale of a stake in the company to G Square Healthcare Private Equity. The partnership will enable CDC to expand its dental care services to other regions…
© Oaklins, all rights reserved. Oaklins refers to Oaklins International Inc. and/or one of its member firms, each of which is a separate legal entity. Please see www.oaklins.com/legal for further details.